Lataa...
Fragment-based discovery of a dual pan-RET/VEGFR2 kinase inhibitor optimized for single-agent polypharmacology()
Oncogenic conversion of the RET (rearranged during transfection) tyrosine kinase is associated with several cancers. A fragment-based chemical screen lead to the identification of a novel RET inhibitor, Pz-1. Modeling and kinetic analysis identified Pz-1 as a Type-II tyrosine kinase inhibitor, able...
Tallennettuna:
| Julkaisussa: | Angew Chem Int Ed Engl |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4535927/ https://ncbi.nlm.nih.gov/pubmed/26126987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201501104 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|